Actively Recruiting
EVASION: Effect of VisuAl Stimulation on attentION
Led by University Hospital, Angers · Updated on 2026-04-06
40
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main objective is to compare changes in information processing speed after 30 days of intervention in participants with a dysexecutive mild cognitive impairment (MCI) and receiving either cognitive stimulation by adapted visual exercises (Emeraude® software) or the broadcasting of a television program without cognitive stimulation. Secondary objectives are: * To compare, after 30 days of intervention, in participants with a dysexecutive MCI and receiving either cognitive stimulation by adapted visual exercises (Emeraude® software), or the broadcasting of a television program without cognitive stimulation : * changes in information processing speed of each subtest, * changes in cognitive performance, * changes in executive functions, * changes in walking performance. * To compare the quality of life, after 30 days of intervention, of participants with a dysexecutive MCI and receiving either cognitive stimulation by adapted visual exercises (Emeraude® software) or the broadcasting of a television program without cognitive stimulation. * In the "Intervention" group, to study correlations between changes in information processing speed index and the final level reached for each cognitive stimulation exercise.
CONDITIONS
Official Title
EVASION: Effect of VisuAl Stimulation on attentION
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 60 years or older
- Diagnosis of mild cognitive impairment of dysexecutive or multidomain dysexecutive type according to Winblad criteria
- Presence of an informal caregiver
- Signed informed consent to participate
- Affiliation to a social security scheme
You will not qualify if you...
- Severe depressive symptoms (Geriatric Depression Scale score > 2)
- Eye or central nervous system conditions affecting stimulation exercise performance
- Regular use of psychotropic drugs affecting exercise performance (benzodiazepines, antidepressants, neuroleptics, hypnotics)
- Use of anticonvulsant drugs
- Presence of confusional syndrome
- Participation in another clinical trial
- Being deprived of liberty by judicial or administrative decision
- Under forced psychiatric care
- Subject to legal protection measures
- Unable to give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Angers University Hospital
Angers, France
Actively Recruiting
Research Team
M
Marine ASFAR, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here